In tumours, this resulted in melanocytic phenotype cells that still expressed high levels of MITF, but had up‐regulated EMT and invasive signatures and corresponding transcription factors such as TEAD1 and AP1 factors (summarized in Figure 6g). Here, MITF is linked to neoplasm.